4.7 Article

Natural product leads for drug discovery: Isolation, synthesis and biological evaluation of 6-cyano-5-methoxyindolo[2,3-a] carbazole based ligands as antibacterial agents

期刊

BIOORGANIC & MEDICINAL CHEMISTRY
卷 17, 期 20, 页码 7126-7130

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2009.08.061

关键词

Carbazole; Anthrax; Tuberculosis

资金

  1. DOD [W81XWH-07-10445]
  2. NIH [1R01GM075856]

向作者/读者索取更多资源

Indolo[2,3-a]carbazole based inhibitors were synthesized from readily available indigo via a seven-step linear synthetic sequence with a moderate overall yield. The inhibitors were selectively and readily functionalized at the nitrogen on the indole portion of the carbazole unit. The synthesized analogs displayed moderate inhibitory activities toward Bacillus anthracis and Mycobacterium tuberculosis, indicating that indolo[2,3-a]carbazoles could serve as promising leads in the development of new drugs to combat anthrax and tuberculosis infections. Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Organic

Quality Control of Therapeutic Peptides by 1H NMR HiFSA Sequencing

Mary P. Choules, Jonathan Bisson, Wei Gao, David C. Lankin, James B. McAlpine, Matthias Niemitz, Birgit U. Jaki, Scott G. Franzblau, Guido F. Pauli

JOURNAL OF ORGANIC CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Development of an Efficient Enzyme Production and Structure-Based Discovery Platform for BACE1 Inhibitors

Yu-Chen Yen, Annalissa M. Kammeyer, Katherine C. Jensen, Jagannadharao Tirlangi, Arun K. Ghosh, Andrew D. Mesecar

BIOCHEMISTRY (2019)

Article Chemistry, Medicinal

1,3-Oxazine-2-one derived dual-targeted molecules against replicating and non-replicating forms of Mycobacterium tuberculosis

Anand Babu Velappan, Dhanunjaya Kesamsetty, Dhrubajyoti Datta, Rui Ma, Natarajan Hari, Scott G. Franzblau, Joy Debnath

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced Solubility

Andrew M. Thompson, Patrick D. O'Connor, Vanessa Yardley, Louis Maes, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper, William A. Denny

Summary: Antitubercular compounds with 7-substituted 2-nitroimidazo[2,1-b]-[1,3]oxazines have shown potent antileishmanial and antitrypanosomal activities. Through exploring different analogues, O-carbamate 66 was identified to have a good balance of increased solubility, suitable metabolic stability, excellent oral bioavailability, and strong in vivo efficacy against visceral leishmaniasis in a mouse model.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Article Biochemistry & Molecular Biology

A Structure-Based Discovery Platform for BACE2 and the Development of Selective BACE Inhibitors

Yu-Chen Yen, Annalissa M. Kammeyer, Jagannadharao Tirlangi, Arun K. Ghosh, Andrew D. Mesecar

Summary: This study developed a platform to produce large amounts of pure BACE2 protein and designed compounds that selectively inhibit BACE1 over BACE2. The research findings could lead to the quicker development of new selective BACE inhibitors for treating Alzheimer's disease or type II diabetes.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Chemistry, Medicinal

Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies

Arun K. Ghosh, Jakka Raghavaiah, Dana Shahabi, Monika Yadav, Brandon J. Anson, Emma K. Lendy, Shin-ichiro Hattori, Nobuyo Higashi-Kuwata, Hiroaki Mitsuya, Andrew D. Mesecar

Summary: This study investigated the synthesis, structure-activity relationship, enzyme inhibition, antiviral activity, and X-ray crystallographic studies of 5-chloropyridinyl indole carboxylate derivatives as potent SARS-CoV-2 chymotrypsin-like protease inhibitors. Compound 1 demonstrated strong inhibitory and antiviral activity, comparable to Remdesivir. Compound 7d showed the most potent enzyme inhibitory activity. X-ray crystal structures of compounds 2, 7b, and 9d bound to SARS-CoV 3CLpro were determined to provide molecular insight into their binding properties.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16

George Minasov, Monica Rosas-Lemus, Ludmilla Shuvalova, Nicole L. Inniss, Joseph S. Brunzelle, Courtney M. Daczkowski, Paul Hoover, Andrew D. Mesecar, Karla J. F. Satchell

Summary: Methylation of viral mRNA caps is essential for translation efficiency, virus replication, and evasion of host cell innate immune responses. The SARS-CoV-2 2'-O-methyltransferase reaction requires divalent cations, preferably Mn2+, and a coronavirus-specific four-residue insert. The unique insert in coronavirus nsp16 alters the capped RNA conformation, making it a potential target for designing selective coronavirus inhibitors.

SCIENCE SIGNALING (2021)

Article Chemistry, Medicinal

Desorption Electrospray Ionization Mass Spectrometry Assay for Label-Free Characterization of SULT2B1b Enzyme Kinetics

Samadhi C. Kulathunga, Nicolas M. Morato, Qing Zhou, R. Graham Cooks, Andrew D. Mesecar

Summary: A novel label-free assay based on high-throughput DESI-MS and a fluorometric coupled-enzyme method were developed for quantitation and kinetic analysis of the sulfonation reaction catalyzed by SULT2B1b. Both methods provided consistent kinetic data and indicated the affinity trend of SULT2B1b with its substrates. The DESI-MS assay has promising potential for identifying SULT2B1b inhibitors as prostate cancer therapeutics and can be applied to other drug discovery efforts.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis

Hamish S. S. Sutherland, Guo-Liang Lu, Amy S. T. G. Tong, Daniel M. Conole, Scott G. U. Franzblau, Anna B. Upton, Manisha U. D. Lotlikar, Christopher B. J. Cooper, Brian D. A. Palmer, Peter J. Choi, William A. Denny

Summary: This study reports tetrahydronaphthalene amides (THNAs) as a new class of ATP synthase inhibitors that effectively inhibit the growth of Mycobacterium tuberculosis (M.tb). The design, synthesis, and structure-activity relationship studies of THNA analogues were conducted, and several compounds with potent in vitro M.tb growth inhibition were identified. Pharmacokinetic and off-target profiling studies were also performed to evaluate the potential of these THNAs as therapeutic options for TB.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Chemical Diversity and Antimicrobial Potential of Cultivable Fungi from Deep-Sea Sediments of the Gulf of Mexico

Rodrigo Villanueva-Silva, Patricia Velez, Meritxell Riquelme, Carlos A. Fajardo-Hernandez, Anahi Martinez-Cardenas, Alejandra Arista-Romero, Baojie Wan, Rui Ma, Mallique Qader, Scott G. Franzblau, Mario Figueroa

Summary: This study isolated and cultivated 29 fungal strains from deep-sea sediments of the Gulf of Mexico, exploring their chemical diversity and antimicrobial potential under different temperature and light conditions. Analysis of LC-MS data revealed that culture temperature is the primary factor influencing the variation of metabolite features. Additionally, bioactivity-guided and conventional chemical studies identified several active and specialized metabolites from selected fungal strains, demonstrating the biosynthetic potential of these marine-derived fungi.

MOLECULES (2021)

Article Chemistry, Medicinal

Optimization of Benzoxazinorifamycins to Improve Mycobacterium tuberculosis RNA Polymerase Inhibition and Treatment of Tuberculosis

Walajapet Rajeswaran, Shireen R. Ashkar, Pil H. Lee, Larisa Yeomans, Yeonoh Shin, Scott G. Franzblau, Katsuhiko S. Murakami, Hollis D. Showalter, George A. Garcia

Summary: In this study, novel benzoxazinorifamycins (bxRIF) were synthesized and tested for their anti-tuberculosis activity. One of the analogues (27a) showed excellent in vitro and in vivo activity against both drug-sensitive and drug-resistant tuberculosis strains. These findings suggest that 27a may be a promising candidate for improving tuberculosis treatment.

ACS INFECTIOUS DISEASES (2022)

Article Chemistry, Medicinal

Optimization of Benzoxazinorifamycins to Minimize hPXR Activation for the Treatment of Tuberculosis and HIV Coinfection

Shireen R. Ashkar, Walajapet Rajeswaran, Pil H. Lee, Larisa Yeomans, Claire M. Thrasher, Scott G. Franzblau, Katsuhiko S. Murakami, Hollis D. Showalter, George A. Garcia

Summary: Tuberculosis is a major global health problem, and current treatments are outdated. Researchers have used a structure-based drug design approach to synthesize and test benzoxazinorifamycins (bxRIFs), finding that some compounds have improved potency and shorter treatment durations. This study demonstrates that the ansamycin core remains an attractive and effective scaffold for novel and improved rifamycins.

ACS INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents

Jidong Zhang, Christine Lair, Christine Roubert, Kwame Amaning, Maria Belen Barrio, Yannick Benedetti, Zhicheng Cui, Zhongliang Xing, Xiaojun Li, Scott G. Franzblau, Nicolas Baurin, Florence Bordon-Pallier, Cathy Cantalloube, Stephanie Sans, Sandra Silve, Isabelle Blanc, Laurent Fraisse, Alexey Rak, Lasse B. Jenner, Gulnara Yusupova, Marat Yusupov, Junjie Zhang, Takushi Kaneko, T. J. Yang, Nader Fotouhi, Eric Nuermberger, Sandeep Tyagi, Fabrice Betoudji, Anna Upton, James C. Sacchettini, Sophie Lagrange

Summary: A series of macrolides called sequanamycins have been discovered, showing outstanding activity against drug-resistant tuberculosis. The lead compound SEQ-9 exhibited efficacy as a single agent and in combination with other TB drugs in mouse models. These findings support further investigation of sequanamycins as potential clinical candidates against drug-resistant TB.
Article Plant Sciences

Isolation and Characterization of Anti-Mycobacterial Natural Products from a Petrosia sp. Marine Sponge

Bhuwan Khatri Chhetri, Riya Bhanushali, Yifan Liang, Marisa R. . Cepeda, Adi Kula Niradininoco, Katy Soapi, Baojie Wan, Mallique Qader, Scot t G. Franzblau, Julia Kubanek

Summary: Tuberculosis is a global health threat, and the development of novel antibiotics with unique mechanisms of action is crucial due to the limited treatment options and the emergence of multidrug-resistant strains. In this study, a compound called duryne was isolated from a marine sponge and showed potential antitubercular activity. Additionally, several new and known compounds were also characterized, providing insights into potential drug candidates for the treatment of tuberculosis.

JOURNAL OF NATURAL PRODUCTS (2023)

Article Chemistry, Medicinal

Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection

Chee Wei Ang, Brendon M. Lee, Colin J. Jackson, Yuehong Wang, Scott G. Franzblau, Amanda F. Francisco, John M. Kelly, Paul Bernhardt, Lendl Tan, Nicholas P. West, Melissa L. Sykes, Alexandra O. Hinton, Raghu Bolisetti, Vicky M. Avery, Matthew A. Cooper, Mark A. T. Blaskovich

Summary: Tuberculosis and parasitic infections pose a significant threat to public health and economic growth worldwide. This study explores a new subclass of bicyclic nitroimidazole compounds and their potential as treatments for tuberculosis and Chagas disease, demonstrating promising results in vitro and in vivo.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

暂无数据